iRhythm SEC filings: 8-K

Filter: All · 8-K · 10-Q · 10-K · Form 4

8-KNov. 5, 2026, 4:15 p.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits
AI summary, unreviewediRhythm Holdings Q3 2026 adjusted EPS of $0.82 beats $0.05 consensus on $221.6 million revenue, in line; FY2026 revenue guidance raised to $890 million-$895 million
8-KOct. 5, 2026, 9:07 a.m. ETView on SEC.gov
Regulation FD disclosure · Financial statements and exhibits
AI summary, unreviewediRhythm Completes $237.5 Million Cash Acquisition of VitalConnect, Expanding Cardiac Monitoring Portfolio
8-KSept. 22, 2026, 5 p.m. ETView on SEC.gov
Regulation FD disclosure
8-KAug. 13, 2026, 4:15 p.m. ETView on SEC.gov
Departure/appointment of directors or officers
8-KAug. 6, 2026, 5:15 p.m. ETView on SEC.gov
Entry into a material definitive agreement · Unregistered sales of equity securities · Financial statements and exhibits
8-KAug. 6, 2026, 4:15 p.m. ETView on SEC.gov
Entry into a material definitive agreement · Results of operations and financial condition · Regulation FD disclosure · Financial statements and exhibits